NCT00291408View on ClinicalTrials.gov

Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Chronic Obstructive Pulmonary Disease (COPD)Age Matched Healthy Volunteers (Non-smokers)
Interventions
PROCEDURE

Skin Prick Test

PROCEDURE

Impulse Oscillometry

PROCEDURE

Exhaled Nitric Oxide

PROCEDURE

Spirometry

PROCEDURE

Reversibility

PROCEDURE

Exhaled Breath Condensate

PROCEDURE

Sputum Induction

Trial Locations (1)

SW3 6LY

Section of Airway Disease, Asthma Lab, Imperial College London, Royal Brompton Hospital, London

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Imperial College London

OTHER